Drug ´breakthrough´ for primary progressive MS

Everyone living with primary progressive multiple sclerosis should be excited by the fact a drug being developed for treatment of that particular type of MS has been given ´breakthrough´ designation by the USA´s Food and Drug Administration (FDA). The special status means that the drug, called ocrelizumab, could be approved more quickly following positive phase …

Advertisement